Gene Amplification in Leishmania tarentolae Selected for Resistance to Sodium Stibogluconate

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.42.7.1689PMID 9661005PMCID PMC105667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing

  2004cited by this paper
• ABC transporters in Leishmania and their role in drug resistance.

  1998cited by this paper
• Amplification of ABC transporter gene pgpA and of other heavy metal resistance genes in Leishmania tarentolae and their study by gene transfection and gene disruption.

  1998cited by this paper
• Co‐amplification of the γ‐glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite‐resistant Leishmania tarentolae

  1997cited by this paper
• Microbial multidrug resistance.

  1997cited by this paper
• Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis.

  1997cited by this paper
• Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis

  1997cited by this paper
• Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania.

  1997influential reference
• An axenic amastigote system for drug screening

  1997cited by this paper
• Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes

  1997influential reference
• In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis

  1997cited by this paper
• Current status of the Plasmodium falciparum genome project.

  1996cited by this paper
• Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae.

  1996cited by this paper
• Toxoplasma gondii expressed sequence tags: insight into tachyzoite gene expression.

  1996cited by this paper
• An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae.

  1996cited by this paper
• Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.

  1996cited by this paper
• cDNA expressed sequence tags of Trypanosoma brucei rhodesiense provide new insights into the biology of the parasite.

  1995cited by this paper
• In vitro antileishmanial properties of tri- and pentavalent antimonial preparations

  1995cited by this paper
• New mechanisms of drug resistance in parasitic protozoa.

  1995cited by this paper
• High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system.

  1994influential reference
• Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistant Leishmania.

  1994cited by this paper
• Autonomous replication of bacterial DNA plasmid oligomers in Leishmania.

  1994cited by this paper
• Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistant Leishmania.

  1994cited by this paper
• Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance.

  1994cited by this paper
• Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania.

  1993cited by this paper
• Practical progress and new drugs for changing patterns of leishmaniasis.

  1993cited by this paper
• Antileishmanial activity of sodium stibogluconate fractions

  1993cited by this paper
• Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.

  1992cited by this paper
• A novel antifolate resistance gene on the amplified H circle of Leishmania.

  1992cited by this paper
• Direct and inverted DNA repeats associated with P‐glycoprotein gene amplification in drug resistant Leishmania.

  1991cited by this paper
• Heavy metal resistance: a new role for P-glycoproteins in Leishmania.

  1991cited by this paper
• Gene amplification in Leishmania.

  1991cited by this paper
• The amplified H circle of methotrexate‐resistant leishmania tarentolae contains a novel P‐glycoprotein gene.

  1990cited by this paper
• Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

  1990cited by this paper
• DNA amplification in arsenite-resistant Leishmania.

  1989cited by this paper
• Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines.

  1989cited by this paper
• Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.

  1989cited by this paper
• The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance.

  1988cited by this paper
• Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).

  1988influential reference
• Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica.

  1983cited by this paper
• Biology of the Kinetoplastida

  1979cited by this paper
• Heavy Metal Resistance : A New Role for P-glycoproteins in Leishmania ”

  year unknowncited by this paper

• The sweet and sour sides of trypanosome social motility.

  2023cites this paper
• Casein kinase 1.2 over expression restores stress resistance to Leishmania donovani HSP23 null mutants

  2020cites this paper
• Interaction of ascaridole, carvacrol, and caryophyllene oxide from essential oil of Chenopodium ambrosioides L. with mitochondria in Leishmania and other eukaryotes

  2018cites this paper
• University of Dundee Characterisation of a putative glutamate 5kinase from Leishmania donovani

  2018cites this paper
• High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms

  2018cites this paper
• Characterisation of a putative glutamate 5‐kinase from Leishmania donovani

  2018cites this paper
• Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.

  2017cites this paper
• A deficiência das proteínas de checkpoint HUS1 e RAD9 promove a variação do número de cópias no genoma de Leishmania major

  2017cites this paper
• Cellular efflux transporters and the potential role of natural products in combating efflux mediated drug resistance.

  2017cites this paper
• Attenuation and Production of the Amphotericin B-Resistant Leishmania tropica Strain

  2016cites this paper
• Leishmania major and Trypanosoma cruzi present distinct DNA damage responses.

  2016cites this paper
• A Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum and Their Properties

  2016cites this paper
• New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites

  2016cites this paper
• Downstream effectors of cyclic adenosine monophosphate signalling in Trypanosoma brucei

  2015cites this paper
• Epidémiologie moléculaire de la résistance de Leishmania aux antimoniés en France et au Maghreb

  2014cites this paper
• Heterogeneity of Molecular Resistance Patterns in Antimony-Resistant Field Isolates of Leishmania Species from the Western Mediterranean Area

  2014cites this paper
• Drug resistance analysis by next generation sequencing in Leishmania

  2014cites this paper
• Inhibitor CpdA Resistance to the Phosphodiesterase RNA Interference Library Screening for Trypanosomes Revealed by Genome-Scale Cyclic AMP Effectors in African

  2013cites this paper
• Cyclic AMP Effectors in African Trypanosomes Revealed by Genome-Scale RNA Interference Library Screening for Resistance to the Phosphodiesterase Inhibitor CpdA

  2013cites this paper
• The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.

  2012cites this paper
• [Differential expression of proteins in Leishmania (Viannia) panamensis associated with mechanisms of resistance to meglumine antimoniate].

  2012cites this paper
• The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.

  2012cites this paper
• Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis.

  2012cites this paper
• Expresión diferencial de proteínas en Leishmania (Viannia) panamensis asociadas con mecanismos de resistencia a antimoniato de meglumina

  2012cites this paper
• DETERMINAÇÃO DA ATIVIDADE LEISHMANICIDA, ANTIPROTEOLÍTICA E ANTIOXIDANTE DE Arrabidaea brachypoda

  2012cites this paper
• Leishmanioses: "estado da arte"

  2011cites this paper
• Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

  2011cites this paper
• Antiprotozoal compounds: state of the art and new developments.

  2011cites this paper
• Genomic Organization of Leishmania Species

  2011cites this paper
• Bio-informatique pour la génomique et le diagnostic des maladies infectieuses

  2011cites this paper
• Antimony Resistance in Leishmania, Focusing on Experimental Research

  2011cites this paper
• Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.

  2010cites this paper
• Differential gene expression studies to explore the molecular mechanism of drug resistance in Leishmania donovani field isolates

  2009cites this paper
• Drug Resistance in Visceral Leishmaniasis

  2009cites this paper
• Roles of Trypanothione S-Transferase and Tryparedoxin Peroxidase in Resistance to Antimonials

  2008cites this paper
• Molecular mechanisms of antimony resistance in Leishmania.

  2007cites this paper
• Characterization of natural antimony resistance in Leishmania donovani isolates.

  2007cites this paper
• Chemotherapy of leishmaniasis: past, present and future.

  2007cites this paper
• Organization of H locus conserved repeats in Leishmania (Viannia) braziliensis correlates with lack of gene amplification and drug resistance

  2007cites this paper
• Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal.

  2007cites this paper
• Papel do transportador ABC PRP1 na resistência à pentamidina em Leishmania spp.

  2007cites this paper
• Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

  2006cites this paper
• Drug resistance mechanisms in clinical isolates of Leishmania donovani.

  2006cites this paper
• Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators.

  2006cites this paper
• Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate.

  2006cites this paper
• Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy

  2005influential citation
• Microbial Genomics as an Integrated Tool for Developing Biosensors for Toxic Trace Elements in the Environment

  2005cites this paper
• The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania

  2004cites this paper
• Leishmaniasis: drugs in the clinic, resistance and new developments.

  2004cites this paper
• Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin*

  2004cites this paper
• Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

  2003cites this paper
• Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays.

  2003cites this paper
• The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis

  2003cites this paper
• Furosemida: mitos y realidades sobre su utilidad en asma

  2003cites this paper
• Novel mechanism of drug resistance in kala azar field isolates.

  2003cites this paper
• Antimony Uptake Systems in the Protozoan Parasite Leishmania and Accumulation Differences in Antimony-Resistant Parasites

  2003cites this paper
• Molecular pharmacology of chemo-resistant Leishmania

  2003cites this paper
• Clinical and Laboratory Aspects of Leishmania Chemotherapy in the Era of Drug Resistance

  2002cites this paper
• Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani.

  2001cites this paper
• Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovani *

  2001cites this paper
• Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates ofLeishmania donovani

  2001cites this paper
• Changes in the infectivity, pyruvate kinase activity, acid phosphatase activity and P-glycoprotein expression in glibenclamide-resistant Leishmania mexicana

  2000cites this paper
• Genomic organization, transcription, splicing and gene regulation in Leishmania.

  1999cites this paper
• Stage-Specific Activity of Pentavalent Antimony against Leishmania donovani Axenic Amastigotes

  1999cites this paper
• Drug resistance in Leishmania: similarities and differences to other organisms.

  1998cites this paper